Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Menopause. 2011 Jan;18(1):23–29. doi: 10.1097/gme.0b013e3181e750dd

Table 2.

Comparison* of C-reactive protein frequency distributions between 10,953 hormone therapy (HT) users and 15,838 HT non-users at the time of the baseline blood collection.

Hormone
Category
Number of
Women
Mean (SD) C-reactive protein (mg/L)
Percentile
5th 10th 25th 50th 75th 90th
HT Non-
users
15,838 3.01 (5.22) 0.19 0.29 0.61 1.51 3.47 6.59
HT Users 10,953 4.67 (6.25) 0.39 0.60 1.38 2.95 5.61 9.14
*

P <0.001 for the comparison of C-reactive protein levels between hormone categories.

HT non-users include never users of HT and past users of HT.